Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
JMIR Neurotechnology is Scopus-indexed (Q2, CiteScore 2.7), DOAJ. Published by JMIR Publications Inc..
Checked against the index lists dated .
ISSN 2817-092XVerify ISSN ↗
Publisher: JMIR Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Rehabilitation | 75 / 172 | 56th | Q2 |
| Neuroscience (miscellaneous) | 45 / 74 | 39th | Q3 |
| Neurology (clinical) | 252 / 403 | 37th | Q3 |
| Health Informatics | 107 / 168 | 36th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q2, CiteScore 2.7.
JMIR Neurotechnology is Q2 in Rehabilitation (rank 75 of 172), Q3 in Neuroscience (miscellaneous) (rank 45 of 74) and Q3 in Neurology (clinical) (rank 252 of 403), by CiteScore 2025. It is ranked in 4 subject areas in all.
JMIR Neurotechnology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.7, quartile Q2, 56th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.471, quartile Q2, with an H-index of 5.
JMIR Neurotechnology is published by JMIR Publications Inc. Its ISSN is 2817-092X.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
JMIR Neurotechnology has an h-index of 9 and a 2-year mean of 5.08 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q2. On 2-year citations it ranks #3 of 168 Scopus journals in Rehabilitation.
JMIR Neurotechnology published 10 papers in 2025; its busiest recent year was 2024 with 13. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 37 research articles (2022–2026), authors are most often from United States (29.1%), Canada (20.9%) and United Kingdom (11.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.